Poyyapakkam R. Srivaths, MD, FAAP
Department or Service
- Texas Medical Center
Medical Director, Pheresis Services
Texas Children's Hospital
Associate Professor, Renal Section, Department of Pediatrics, Baylor College of Medicine
|Baylor College of Medicine||fellowship||Pediatric Nephrology||2009|
|Cook County Hospital||residency||Pediatrics||2001|
|Children's Hospital of Michigan||fellowship||Pediatric Critical Care||1999|
|Maulana Azad Medical College, Delhi||medical school||Doctor of Medicine||1995|
|Kilpauk Medical College||medical school||Bachelor of Medicine & Surgery||1991|
Dr. Srivaths is committed to providing excellent patient and family centered general nephrology care to the communities in and around Houston. His clinical expertise extends to all forms of renal disease both congenital and acquired. He manages a multi-disciplinary pheresis program that provides acute and chronic services, including but not limited to stem cell collection for bone marrow transplantation, white cell depletion for leukemia, red cell exchange for sickle cell anemia, plasma exchange for thrombotic microangiopathy, and plasmapheresis for numerous antibody-mediated systemic diseases.
• End Stage Kidney Disease (ESKD)
• Peritoneal dialysis
• Kidney Transplantation
Dr. Srivaths' research focus is investigating cardiovascular morbidity associated with end stage renal disease (ESRD) in children. He and his colleagues have shown that cardiac calcifications are highly prevalent children receiving chronic hemodialysis. They have also shown novel associations of newer markers of mineral imbalance such as FGF 23 to be associated with cardiac calcifications. He has started studying potential role of modality differences in prevalence of cardiac calcifications, expanding this research to assess cardiac calcifications in children receiving peritoneal dialysis and is also undertaking a project comparing calcifications and vascular compliance in children with ESRD.
|American Academy of Pediatrics||Fellow|
|American Society of Apheresis||Member|
|American Society of Nephrology||Member|
|American Society of Pediatric Nephrology||Program Committee Member|
|cKID (Chronic Kidney Disease in Children) Study||site-PI|
|Indian Academy of Pediatrics||Life Member|
|International Pediatric Nephrology Association (IPNA)||Member|
|National Kidney Foundation||Member|
|Organization Prep - Nephrology||Advisory Board|
|Society of Pediatric Research||Member|
Rodriguez K, Srivaths PR, Tal L, Watson MN, Riley AA, Himes RW, Desai MS, Braun MC, Akcan Arikan A. Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure. PLoS One 12(8):e0182134. PubMed PMC5549692, 2017.
Wong Vega M, Srivaths PR. Air Displacement Plethysmography versus Bioelectrical Impedance to Determine Body Composition in Pediatric Hemodialysis Patients. Journal of Renal Nutrition 27(6):439-444. PubMed PMID: 28602463, 2017.
Geer JJ, Shah S, Williams E, Arikan AA, Srivaths P. Faster rate of blood volume change in pediatric hemodialysis patients impairs cardiac index. Pediatric Nephrology 32(2):341-345. PubMed PMID: 27553912, 2017.
Lee J, Imani P, Geer J, Braun M, Srivaths P, Orjuela A. The Pharmacokinetics of Intradialytic Administration of Eculizumab in an Infant. American Journal of Kidney Diseases 66(6):1105-6. PubMed PMID: 26363847, 2015.
Geer JJ, Braun MC, Srivaths PR. Using a non-invasive method in chronic hemodialysis pediatric patients to estimate hemoglobin. Pediatric Nephrology 30(4):661-4. PubMed PMID: 25322906, 2015.
ViiCTR Profile: https://profiles.viictr.org/display/BCM/poyyapakkam-srivaths